Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore
Magdalena Juhaszova, … , Eric N. Olson, Steven J. Sollott
Magdalena Juhaszova, … , Eric N. Olson, Steven J. Sollott
Published June 1, 2004
Citation Information: J Clin Invest. 2004;113(11):1535-1549. https://doi.org/10.1172/JCI19906.
View: Text | PDF
Article Cell biology

Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore

  • Text
  • PDF
Abstract

Environmental stresses converge on the mitochondria that can trigger or inhibit cell death. Excitable, postmitotic cells, in response to sublethal noxious stress, engage mechanisms that afford protection from subsequent insults. We show that reoxygenation after prolonged hypoxia reduces the reactive oxygen species (ROS) threshold for the mitochondrial permeability transition (MPT) in cardiomyocytes and that cell survival is steeply negatively correlated with the fraction of depolarized mitochondria. Cell protection that exhibits a memory (preconditioning) results from triggered mitochondrial swelling that causes enhanced substrate oxidation and ROS production, leading to redox activation of PKC, which inhibits glycogen synthase kinase-3β (GSK-3β). Alternatively, receptor tyrosine kinase or certain G protein–coupled receptor activation elicits cell protection (without mitochondrial swelling or durable memory) by inhibiting GSK-3β, via protein kinase B/Akt and mTOR/p70s6k pathways, PKC pathways, or protein kinase A pathways. The convergence of these pathways via inhibition of GSK-3β on the end effector, the permeability transition pore complex, to limit MPT induction is the general mechanism of cardiomyocyte protection.

Authors

Magdalena Juhaszova, Dmitry B. Zorov, Suhn-Hee Kim, Salvatore Pepe, Qin Fu, Kenneth W. Fishbein, Bruce D. Ziman, Su Wang, Kirsti Ytrehus, Christopher L. Antos, Eric N. Olson, Steven J. Sollott

×

Figure 4

Options: View larger image (or click on image) Download as PowerPoint
Mechanisms of protection dependent on mitochondrial swelling. (A) Enhanc...
Mechanisms of protection dependent on mitochondrial swelling. (A) Enhanced ROS generation (in DCF-loaded cells, n > 50) during mitoKATP activation by Dz. *P < 0.02 vs. control. (B) Assessment of change in mitochondrial volume after Dz treatment by Fourier analysis. Laser line-scan imaging of in situ mitochondria was performed along the long axis of the cell (right panels) during Dz exposure. High-resolution transmittance (gray image) and flavoprotein autofluorescence (488 nm excitation, green image) were obtained simultaneously. The left panel shows the Fourier frequency-domain spectrum from the transmittance line-scan data during the control period and periods of treatment with Dz for 10 and 20 minutes. The first-order peak indicates the regular sarcomere Z structure. The spectrum inset enlarges the second-order peak shifts (converted to micrometer scale), indicating small Dz-mediated changes in mitochondrial volume. Arb scale, arbitrary scale; FP flavoproteins. (C and D) Mitochondrial-volume changes induced by swellers and nonswellers (“SB” indicates SB 415286). C (right panel) and D show time-dependent volume changes after Hoe, and the reversal of the swelling effect by inhibition of Cl_ transport using IAA94 (D). Ins, insulin. (E) Protection by mitochondrial swellers (but not by nonswellers) requires Cl_ channel flux. (F) Osmotic change induces modulation of tMPT measured under isotonic conditions and 15 minutes after transient (5 minutes) hypotonic conditions. **P < 0.01 (and all bars under brace) vs. control (E and F).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts